ALLR Stock Analysis: Buy, Sell, or Hold?
ALLR - Allarity Therapeutics, Inc. Common Stock
$1.32
-0.04 (-2.94%)
▼
5d:
-10.81%
30d:
-20.48%
90d:
+15.79%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: May 08, 2026
0d
Get Alerted When ALLR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ALLR is down 10.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ALLR is down 10.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ALLR is currently trading at $1.32, which is considered oversold relative to its 30-day fair value range of $1.41 to $1.68.
Technical Outlook: Technically, ALLR is in a strong uptrend. Immediate support is located at $1.27, while resistance sits at $1.66.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.25 (+676.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALLR is in a strong uptrend. Immediate support is located at $1.27, while resistance sits at $1.66.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.25 (+676.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.41 -
$1.68
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 676.5% below Wall St target ($10.25)
- WARNING: Recommendation downgraded due to -10.8% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.41 -
$1.68
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.27
Resistance Level
$1.66
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.36
Wall Street Target
$10.25
(+676.5%)
Share & Embed Analysis
Last updated: June 23, 2026 7:40 PM ET
Data refreshes hourly during market hours. Next update: 8:40 PM
Data refreshes hourly during market hours. Next update: 8:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALLR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 64 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 62 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 65 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 61 BUY |
